![Updated Clinical Practice Guidelines in Oncology for Imetelstat – MDS Foundation](https://oncodaily.com/pub/uploads/2024/08/drug-capsule-pill-from-drug-prescription-in-drugstore-pharmacy-for-treatment-health-medicine-photo-1280x853.jpg)
Aug 2, 2024, 01:25
Updated Clinical Practice Guidelines in Oncology for Imetelstat – MDS Foundation
MDS Foundation shared on X:
“On July 26th, 2024, the National Comprehensive Cancer Network updated its Clinical Practice Guidelines in Oncology for MDS. RYTELO™ (imetelstat) is now recommended as a Category 1 and 2A treatment for symptomatic anemia in patients with lower-risk MDS.”
Source : MDS Foundation/X